Cite
List prices and clinical value of anticancer drugs in China, Japan, and South Korea: a retrospective comparative study.
MLA
Pan, Jay, et al. “List Prices and Clinical Value of Anticancer Drugs in China, Japan, and South Korea: A Retrospective Comparative Study.” The Lancet Regional Health. Western Pacific, vol. 47, May 2024, p. 101088. EBSCOhost, https://doi.org/10.1016/j.lanwpc.2024.101088.
APA
Pan, J., Wei, X., Lu, H., Wu, X., Li, C., Hai, X., Lan, T., Dong, Q., Yang, Y., Jakovljevic, M., & Zhou, J. (2024). List prices and clinical value of anticancer drugs in China, Japan, and South Korea: a retrospective comparative study. The Lancet Regional Health. Western Pacific, 47, 101088. https://doi.org/10.1016/j.lanwpc.2024.101088
Chicago
Pan, Jay, Xiaolin Wei, Hao Lu, Xueer Wu, Chunyuan Li, Xuelian Hai, Tianjiao Lan, et al. 2024. “List Prices and Clinical Value of Anticancer Drugs in China, Japan, and South Korea: A Retrospective Comparative Study.” The Lancet Regional Health. Western Pacific 47 (May): 101088. doi:10.1016/j.lanwpc.2024.101088.